Every week, new regulatory measures, health alerts, or changes in the healthcare system modify the way the French access health services. Keeping up with health news daily allows for anticipating these changes rather than merely enduring them. Here are recent topics that deserve special attention, along with their concrete consequences.
Legal ceiling on sick leave: what the September 2026 decree changes
A decree dated June 12, 2026 (n° 2026-498) fundamentally alters the prescription of sick leave starting September 1, 2026. Until now, the duration of an initial sick leave largely depended on the assessment of the treating physician.
The new framework is stricter: the initial sick leave is limited to one month, and the extension to two months. Exceptions are still provided for long-term illnesses and serious pathologies, but the general principle changes.
For patients, this means more frequent medical follow-ups. A three-month leave will now require at least two renewal consultations. For doctors, the administrative burden increases, while medical deserts already complicate access to appointments. The sections on health news on Pharmavia regularly detail this type of regulatory evolution and its effects on the care pathway.
Are you an employee or an employer? Check now if your collective agreements provide for complementary provisions. The decree does not abolish more favorable branch agreements, but it sets a national floor.
Extension of 100% Health to wheelchairs and hair prostheses
The 100% Health scheme, initially launched for optics, dental care, and hearing aids, is expanding to new equipment. Since December 2025, short-term rental of certain wheelchairs is covered with no out-of-pocket costs, for a period of up to six months over a rolling year.
This measure concerns manual, electric, and certain specific models of wheelchairs. It targets patients with temporary disabilities (complex fractures, post-operative rehabilitation) who may not always have the means to rent suitable equipment.
Hair prostheses are also included in the scope. For a person undergoing chemotherapy, the cost of a prosthesis could represent several hundred euros in out-of-pocket expenses. The 100% Health scheme eliminates this financial barrier for the models listed in the basket with no out-of-pocket costs.
Check your eligibility with your supplementary insurance
The full reimbursement relies on the coordination between Health Insurance and the mutual insurance. All responsible complementary health contracts cover the 100% Health basket, but the reimbursement timelines vary. Before ordering equipment, request a quote and send it to your organization.
Health insurance reform in 2026: freeze on rates and supplementary insurance
The issue of mutual insurance costs comes up every year. In 2026, two measures stand out:
- A temporary freeze on the rates of certain complementary health insurances has been negotiated as part of the Social Security financing bill, to limit the increase in contributions that had reached significant levels in recent years.
- A 20.5% tax on supplementary insurance contracts reignites the debate on the usefulness of these additional coverages. For insured individuals who combine mutual insurance and supplementary insurance, the fiscal surcharge could make supplementary insurance less advantageous.
- The reform of health data sharing, framed by law 2026-534, redefines the conditions under which insurance organizations access medical information, with a strengthening of medical confidentiality.
These three topics are interconnected. The freeze on rates aims to protect purchasing power, but it could also push some insurers to reduce their optional guarantees. Compare the guarantee tables before renewing your contract.
Health prevention in France: a harsh senatorial report
A senatorial report published in 2026 presents a critical assessment of prevention policy in France. The diagnosis is clear: prevention spending is increasing but remains insufficiently prioritized compared to curative care.
In concrete terms, France invests more in treating diseases than in preventing them. Cancer screening campaigns, vaccination, and the fight against alcohol and tobacco receive funding, but their coordination remains fragmented among regional health agencies, local authorities, and city professionals.
Heatwaves and chronic diseases: an example of poorly calibrated prevention
Heatwave episodes illustrate this gap. Public Health France publishes regional bulletins (like the one from July 3, 2026, for Île-de-France) with surveillance data, but the information struggles to reach the most vulnerable patients. Individuals undergoing treatment for chronic diseases, particularly cardiovascular ones, sometimes need to adjust their medication during periods of extreme heat.
Have you checked if your medications require special precautions during a heatwave? Some diuretics or antihypertensives alter the body’s thermal regulation. Discuss this with your doctor or pharmacist before each heat episode.
Keeping up with health news without drowning in information
Between decrees, reports, epidemic alerts, and reimbursement changes, the volume of health information can be overwhelming. A few guidelines help to sort through:
- Favor institutional sources (Public Health France, Health Insurance) for epidemiological data and reimbursement changes.
- For health products and medications, public databases like that of the ANSM remain the reference for adverse effects and market withdrawals.
- Specialized portals in pharmacy and medical research allow for cross-referencing information and verifying that an announcement corresponds to an official published text.
The most useful reflex remains to check the date and source before sharing health information. An announced decree is not a published decree. A preliminary study is not a treatment recommendation. This distinction prevents the majority of false alerts circulating on social media.